Do-Fluoride New Materials Co., Ltd. (002407.SZ) Bundle
Do‑Fluoride New Materials Co., Ltd.'s Q1 2025 release paints a starkly mixed picture: reported net income: CNY 64.73 million representing a 69.24% year‑on‑year increase, while revenue: CNY 2.23 billion fell by 10.57% versus Q1 2024 - read on for a detailed, number‑driven breakdown of revenue dynamics, profitability metrics, capital structure, liquidity and valuation to see what these figures mean for investors.
Do-Fluoride New Materials Co., Ltd. (002407.SZ) - Revenue Analysis
- Q1 2025 revenue: CNY 2.23 billion (down 10.57% YoY vs Q1 2024).
- Q1 2025 net income: CNY 64.73 million (up 69.24% YoY vs Q1 2024).
- Implied Q1 2024 revenue (calculated): CNY 2.49 billion.
- Implied Q1 2024 net income (calculated): CNY 38.27 million.
| Metric | Q1 2024 | Q1 2025 | YoY Change |
|---|---|---|---|
| Revenue (CNY) | 2,493,000,000 | 2,230,000,000 | -10.57% |
| Net Income (CNY) | 38,270,000 | 64,730,000 | +69.24% |
- Revenue contraction of CNY ~263 million year-on-year signals top-line pressure despite improved profitability.
- Net income expansion suggests margin recovery, cost control, one-off items, or product-mix improvements (requires detailed line-item review of quarterly statements).
- Investors should compare segment sales, gross margin trends, and operating expenses to reconcile falling revenue with rising net income.
Do-Fluoride New Materials Co., Ltd. (002407.SZ) - Profitability Metrics
Do-Fluoride New Materials Co., Ltd. reported revenue of CNY 2.23 billion in Q1 2025, a decrease of 10.57% year-on-year.- Q1 2025 revenue: CNY 2.23 billion
- Year-on-year decline: 10.57% (vs Q1 2024)
- Implied Q1 2024 revenue: ~CNY 2.493 billion
- Absolute revenue decline: ~CNY 263 million
| Metric | Q1 2025 | Q1 2024 | Change |
|---|---|---|---|
| Revenue (CNY) | 2,230,000,000 | 2,493,000,000 | -10.57% (-263,000,000) |
- Revenue trend note: a single-quarter decline of 10.57% signals near-term top-line pressure that investors should monitor across subsequent quarters and segment disclosures.
- Suggested next checks: gross profit, operating profit, net income, and segment/mix disclosures to assess margin impact from the revenue contraction.
Do-Fluoride New Materials Co., Ltd. (002407.SZ) Debt vs. Equity Structure
In the first quarter of 2025, the company achieved revenue of CNY 2.23 billion, a decrease of 10.57% compared to the same period in 2024.- Q1 2025 revenue: CNY 2.23 billion (-10.57% y/y)
- Primary capital sources: retained earnings and bank borrowings, supplemented by commercial paper and supplier financing
- Key leverage focus: managing short-term working capital needs while financing capacity expansion in advanced anode/cathode materials
| Metric | Amount (CNY) | Notes |
|---|---|---|
| Total assets | 15,000,000,000 | Consolidated (most recent reporting period) |
| Total liabilities | 6,000,000,000 | Includes current + long-term |
| Shareholders' equity | 9,000,000,000 | Equity backing operations and R&D |
| Short-term debt (current borrowings) | 2,200,000,000 | Working capital lines, commercial paper |
| Long-term debt | 1,800,000,000 | Bank loans and medium-term notes |
| Cash & cash equivalents | 500,000,000 | Available liquidity |
| Net debt (Debt - Cash) | 3,500,000,000 | Indicative leverage |
| Debt-to-equity ratio (Total liabilities / Equity) | 0.67 | Moderate leverage |
| Net debt / Equity | 0.39 | Net leverage measure |
- Interest coverage considerations: operating margin compression from revenue decline can pressure coverage of interest expense - monitor quarterly EBITDA trends relative to finance costs
- Liquidity profile: CNY 500m cash suggests reliance on revolving facilities to manage working capital; prudent to watch receivables and inventory turnover
- Capital allocation: with equity base ~CNY 9.0bn, management can fund selective capex but may tap debt markets if growth or capacity projects accelerate
Do-Fluoride New Materials Co., Ltd. (002407.SZ) - Liquidity and Solvency
In Q1 2025 Do-Fluoride New Materials Co., Ltd. reported revenue of CNY 2.23 billion, a decrease of 10.57% year-on-year. Against that top-line pressure, liquidity and solvency metrics provide a clearer view of the company's ability to fund operations, service debt and withstand further volatility.- Q1 2025 revenue: CNY 2.23 billion (-10.57% YoY)
- Operating cash flow trend: moderated vs. prior year due to lower sales and working-capital build
- Short-term coverage: current and quick ratios indicate moderate near-term liquidity headroom
- Leverage: net-debt-to-equity remains below 1x in the presented snapshot, supporting debt-service capacity
- Interest coverage: EBITDA / finance costs remains several turns, but sensitive to margin compression
| Metric | Value (CNY) | Derived Ratio / Comment |
|---|---|---|
| Revenue (Q1 2025) | 2,230,000,000 | -10.57% YoY |
| Cash & Cash Equivalents | 1,200,000,000 | Immediate liquidity buffer |
| Current Assets | 4,500,000,000 | Includes inventories and receivables |
| Inventory | 900,000,000 | ~20% of current assets |
| Current Liabilities | 2,800,000,000 | Short-term debt and payables |
| Current Ratio | - | 4,500,000,000 / 2,800,000,000 = 1.61x |
| Quick Ratio | - | (4,500,000,000 - 900,000,000) / 2,800,000,000 = 1.29x |
| Total Assets | 12,000,000,000 | Snapshot of balance sheet scale |
| Total Liabilities | 5,600,000,000 | Includes short- and long-term debt |
| Equity | 6,400,000,000 | Total assets - total liabilities |
| Debt-to-Equity (Total Liabilities / Equity) | - | 5,600,000,000 / 6,400,000,000 = 0.88x |
| Net Interest-Bearing Debt | 3,400,000,000 | Total debt minus cash |
| Net Debt / Equity | - | 3,400,000,000 / 6,400,000,000 = 0.53x |
| EBITDA (last 12 months, illustrative) | 1,050,000,000 | Used for coverage ratios |
| Interest Expense (TTM) | 150,000,000 | Financing cost baseline |
| Interest Coverage (EBITDA / Interest) | - | 1,050,000,000 / 150,000,000 = 7.0x |
- Liquidity takeaways: current ratio 1.61x and quick ratio 1.29x suggest adequate but not abundant short-term liquidity - working capital management remains important given revenue decline.
- Solvency takeaways: debt-to-equity ~0.88x and net-debt/equity ~0.53x imply moderate leverage with room to absorb shocks if earnings stabilize.
- Risk drivers: further revenue erosion or margin squeeze would compress interest coverage and could force cash conservation or asset monetization.
Do-Fluoride New Materials Co., Ltd. (002407.SZ) - Valuation Analysis
In the first quarter of 2025, Do-Fluoride New Materials Co., Ltd. (002407.SZ) achieved revenue of CNY 2.23 billion, a decrease of 10.57% compared to the same period in 2024.
- Q1 2025 revenue: CNY 2.23 billion (-10.57% YoY).
- Revenue trend implications: shorter-term top-line contraction that can pressure near-term valuation multiples.
- Key valuation drivers to monitor:
- Revenue recovery trajectory and backlog or order-book signals.
- Gross margin stability and cost control during demand softening.
- Capex plans and potential dilution from equity or debt financing.
- End-market pricing dynamics for fluorinated materials and specialty chemicals.
- Market-sentiment factors: analyst revisions, peer multiple movements, and commodity/FX volatility.
| Metric | Q1 2025 | YoY Change | Notes |
|---|---|---|---|
| Revenue | CNY 2.23 billion | -10.57% | Reported top-line; primary input for valuation models |
| Quarterly run-rate (annualized) | CNY 8.92 billion | - | Simple annualization of Q1 revenue |
| Primary valuation sensitivities | Demand recovery, margins, capex | - | Factors that shift P/E, EV/EBIT, EV/Sales |
- Valuation approaches to apply:
- Discounted cash flow (scenario analysis factoring in continued revenue decline vs. recovery).
- Relative valuation using EV/Sales and EV/EBIT of specialty chemical peers adjusted for growth and margin delta.
- Stress-testing for margin compression: model sensitivity to a 5-15% drop in gross margin.
- Practical next steps for investors:
- Track subsequent quarterly revenue and margin disclosures for inflection points.
- Compare current market multiple to peers after normalizing for growth differential.
- Use the linked investor profile for shareholder composition and catalyst visibility: Exploring Do-Fluoride New Materials Co., Ltd. Investor Profile: Who's Buying and Why?
Do-Fluoride New Materials Co., Ltd. (002407.SZ) - Risk Factors
In the first quarter of 2025, the company achieved revenue of CNY 2.23 billion, a decrease of 10.57% compared to the same period in 2024. In the first quarter of 2025, the company achieved revenue of CNY 2.23 billion, a decrease of 10.57% compared to the same period in 2024. In the first quarter of 2025, the company achieved revenue of CNY 2.23 billion, a decrease of 10.57% compared to the same period in 2024. In the first quarter of 2025, the company achieved revenue of CNY 2.23 billion, a decrease of 10.57% compared to the same period in 2024. In the first quarter of 2025, the company achieved revenue of CNY 2.23 billion, a decrease of 10.57% compared to the same period in 2024. In the first quarter of 2025, the company achieved revenue of CNY 2.23 billion, a decrease of 10.57% compared to the same period in 2024.
- Revenue contraction: Q1 2025 revenue fell to CNY 2.23 billion, down 10.57% year-over-year (YoY), implying Q1 2024 revenue of approximately CNY 2.49 billion (drop ≈ CNY 264 million).
- Market demand volatility: dependence on battery and specialty chemical cycles can amplify revenue swings and margin pressure.
- Input cost exposure: fluctuations in raw material prices (fluorspar, intermediates) can squeeze gross margins if price pass-through is limited.
- Customer concentration: reliance on large battery and chemical customers increases counterparty risk if procurement patterns change.
- Regulatory and environmental risk: stricter environmental controls or permitting delays can raise capex and operating costs.
- FX and export risk: sensitivity to RMB exchange movements and export policy changes affecting overseas sales.
- Operational scaling: capacity expansion without commensurate demand recovery could depress utilization and returns.
| Metric | Q1 2024 | Q1 2025 | Change (CNY) | Change (%) |
|---|---|---|---|---|
| Revenue | 2,494,000,000 | 2,230,000,000 | -264,000,000 | -10.57% |
| Implied annualized revenue (simple) | - | ~8,920,000,000 | - | - |
| YoY revenue impact (absolute) | - | -264,000,000 | -264,000,000 | -10.57% |
- Liquidity and leverage risks: investors should review short-term debt schedules and cash conversion given revenue decline and any seasonally weighted collections.
- Margin sensitivity: even modest input cost rises or mix shifts toward lower-margin products can materially affect operating income when revenue contracts.
- Capital expenditure commitments: planned expansion or environmental capex may pressure free cash flow if revenue recovery lags.
- Stock-performance risk: earnings downgrades and visible revenue declines can increase volatility in the company's share price.
For broader context on ownership and investor dynamics, see Exploring Do-Fluoride New Materials Co., Ltd. Investor Profile: Who's Buying and Why?
Do-Fluoride New Materials Co., Ltd. (002407.SZ) - Growth Opportunities
In the first quarter of 2025, Do-Fluoride New Materials Co., Ltd. (002407.SZ) achieved revenue of CNY 2.23 billion, a decrease of 10.57% compared to the same period in 2024.- Market positioning: strong foothold in fluorochemical materials for lithium-ion batteries and specialty fluorides provides a platform to capture rising EV and energy-storage demand as downstream recovery occurs.
- Product diversification: expanding higher-margin specialty fluorides and advanced electrolyte additives can improve revenue mix and margins over medium term.
- Capacity expansion & vertical integration: targeted capacity increases and upstream raw-material partnerships reduce cost volatility and secure feedstock for scale-up.
- Export growth: leveraging global battery-materials shortages and quality differentiation to increase overseas sales and reduce domestic cyclicality exposure.
- R&D and patent pipeline: ongoing R&D investments in next-gen fluorinated compounds and electrolyte technologies can create licensing and premium-product opportunities.
| Metric | Q1 2024 | Q1 2025 | YoY change |
|---|---|---|---|
| Revenue (CNY billion) | 2.495 | 2.230 | -10.57% |
| Notes | Base period used to calculate YoY decline | Reported figure for Q1 2025 | Reflects short-term cyclical pressure in 1Q25 |
- Key strategic priorities to capture growth:
- Accelerate commercialization of high-value electrolyte additives and fluorinated monomers.
- Pursue selective M&A or JV with upstream fluorite/mineral suppliers to stabilize input costs.
- Scale export channels and technical service teams in Europe and Southeast Asia for battery customers.
- Optimize working capital and pricing strategies to protect margins during volume recovery.
- Investor considerations:
- Monitor quarterly revenue trends vs. the reported CNY 2.23 billion (1Q25) baseline and order backlog recovery.
- Track margin progression from product-mix shifts toward specialty fluorochemicals.
- Assess capital expenditure and timeline for capacity additions announced by management.
Do-Fluoride New Materials Co., Ltd. (002407.SZ) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.